| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.CIR.88.6.2838 |
| P698 | PubMed publication ID | 8252697 |
| P2093 | author name string | T Finkel | |
| P Lemarchand | |||
| R G Crystal | |||
| S E Epstein | |||
| R J Guzman | |||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Adenoviridae | Q193447 |
| P304 | page(s) | 2838-2848 | |
| P577 | publication date | 1993-12-01 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Efficient and selective adenovirus-mediated gene transfer into vascular neointima | |
| P478 | volume | 88 |
| Q33807737 | Adeno-associated virus-mediated transfer of endothelial nitric oxide synthase gene reduces the vasoconstrictive response. |
| Q41671821 | Adenovirus gene therapy for hypercholesterolemia, thrombosis and restenosis |
| Q35769081 | Adenovirus-mediated gene transfer into normal rabbit arteries results in prolonged vascular cell activation, inflammation, and neointimal hyperplasia |
| Q39416600 | Adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene inhibits vascular smooth muscle cell proliferation and neointima formation following balloon angioplasty of the rat carotid artery |
| Q42796316 | Adenovirus-mediated transfer of the smooth muscle cell calponin gene inhibits proliferation of smooth muscle cells and fibroblasts |
| Q37766138 | Advances in gene-based therapy for heart failure |
| Q33282855 | Biocompatible micellar nanovectors achieve efficient gene transfer to vascular lesions without cytotoxicity and thrombus formation. |
| Q34409721 | Cardiac Gene Therapy |
| Q37811189 | Cardiac gene therapy with SERCA2a: From bench to bedside |
| Q38820937 | Cardiac gene therapy: are we there yet? |
| Q45880882 | Co-expression of fibulin-5 and VEGF165 increases long-term patency of synthetic vascular grafts seeded with autologous endothelial cells |
| Q40649909 | Constitutively active form of natriuretic peptide receptor 2 ameliorates experimental pulmonary arterial hypertension |
| Q40963397 | Current aspects of gene therapy: implications for vascular interventions |
| Q41146437 | Development of recombinant adenoviruses that drive high level expression of the human metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 and -2 genes: characterization of their infection into rabbit smooth muscle cells and human MCF-7 a |
| Q38573400 | Direct gene transfer into donor hearts at the time of harvest |
| Q37633078 | Drug- and Gene-eluting Stents for Preventing Coronary Restenosis |
| Q45870659 | Effect of percutaneous adenovirus-mediated Gax gene delivery to the arterial wall in double-injured atheromatous stented rabbit iliac arteries |
| Q45855882 | Efficient in vivo catheter-based pericardial gene transfer mediated by adenoviral vectors. |
| Q42066164 | Efficient transduction of vascular smooth muscle cells with a translational AAV2.5 vector: a new perspective for in-stent restenosis gene therapy |
| Q36961302 | Endothelial Bmp4 is induced during arterial remodeling: effects on smooth muscle cell migration and proliferation |
| Q37362429 | Established immunity precludes adenovirus-mediated gene transfer in rat carotid arteries. Potential for immunosuppression and vector engineering to overcome barriers of immunity |
| Q42458857 | Expression of coxsackievirus and adenovirus receptor in neointima of the rat carotid artery |
| Q40464187 | Gene therapy for the vulnerable plaque |
| Q30409346 | Gene therapy in the inner ear using adenovirus vectors |
| Q40746287 | Gene transfer to blood vessels using adenoviral vectors |
| Q41526863 | Human adenovirus vectors for gene transfer into mammalian cells |
| Q45870761 | Impact of polyplex micelles installed with cyclic RGD peptide as ligand on gene delivery to vascular lesions. |
| Q57083728 | Improved in situ ?-galactosidase staining for histological analysis of transgenic mice |
| Q43845483 | In vitro growth suppression of vascular smooth muscle cells using adenovirus-mediated gene transfer of a truncated form of fibroblast growth factor receptor |
| Q48750778 | In vivo liposome-mediated transfection of HLA-DR alpha-chain gene into pig hearts |
| Q35871957 | In vivo suppression of injury-induced vascular smooth muscle cell accumulation using adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene |
| Q39795032 | Inhibition of rat vascular smooth muscle proliferation in vitro and in vivo by bone morphogenetic protein-2. |
| Q34223710 | Low-efficiency of percutaneous adenovirus-mediated arterial gene transfer in the atherosclerotic rabbit |
| Q77522059 | Medical therapies for the prevention of restenosis after percutaneous coronary interventions |
| Q45883319 | Novel methods for adenovirus-mediated gene transfer to blood vessels in vivo |
| Q35214863 | Preventing saphenous vein graft failure: does gene therapy have a role? |
| Q37381258 | Protection from reoxygenation injury by inhibition of rac1. |
| Q37357232 | Regulation of cellular proliferation and intimal formation following balloon injury in atherosclerotic rabbit arteries |
| Q34757960 | Rescuing the failing heart by targeted gene transfer |
| Q43839319 | Selective neointimal gene transfer in an avian model of vascular injury |
| Q45862541 | Targeting an adenoviral gene vector to cytokine-activated vascular endothelium via E-selectin |
| Q45861484 | Targeting endogenous platelet-derived growth factor B-chain by adenovirus-mediated gene transfer potently inhibits in vivo smooth muscle proliferation after arterial injury |
| Q36647187 | The Gordon Wilson Lecture. In vivo gene therapy: a strategy to use human genes as therapeutics |
| Q45883719 | The absence of accessible vitronectin receptors in differentiated tissue hinders adenoviral-mediated gene transfer to the intestinal epithelium in vitro |
| Q34056687 | Topic review: surface modifications enhancing biological activity of guglielmi detachable coils in treating intracranial aneurysms |
| Q45872181 | Ultrasound-contrast agent mediated naked gene delivery in the peritoneal cavity of adult rat. |
| Q41022452 | Vascular access stenosis: prospects for prevention and therapy |
| Q42574783 | Vascular disease: the next target for local molecular therapeutics |
| Q45883103 | Viral-mediated gene transfer in the cochlea |
Search more.